Free Online CME

Disease Management Clinical Decisions

Community-acquired pneumonia

Print this Content

Release date: December 1, 2021
Expiration date: December 1, 2024

Estimated Time of Completion: 1 hour

Description

Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.

DISCLAIMER: This activity refers to adults patients in the United States with no recent foreign travel, who do not have any immunocompromising condition either inherited or acquired, are not actively receiving cancer-related therapy, are not know to have human immunodeficiency virus disease with low CD4 count, and are not recipients of a solid organ or bone marrow transplant. Also, the information discussed here is outside the context of the current COVID-19 pandemic.

Learning Objectives

After completing this case the reader should be able to:

  • Describe the risk factors and the diagnosis of community-acquired pneumonia (CAP).
  • List the most common causes of CAP and describe how they have changed over time.
  • Summarize the advantage of clinical prediction rules and use them to appropriately triage patients with CAP.
  • Describe the recommendations for diagnostic testing in patients with CAP.
  • Provide guideline-based treatment for patients with CAP and describe the supporting evidence.

Target Audience

Directed to primary care physicians including family practitioners and internists.

Accreditation

In support of improving patient care, Cleveland Clinic Center for Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.

ABA MOC: This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.
Maintenance of Certification in AnesthesiologyTM program and MOCA® are registered trademarks of The American Board of Anesthesiology®. MOCA 2.0® is a trademark of The American Board of Anesthesiology®. 
Your credit will be reported to the ABA within 30 days of claiming credit. 

ABIM MOC:  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Your credit will be reported to the ABIM within 30 days of claiming credit. 

ABO MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning, Self-Assessment, Improvement in Medical Practice and/or Patient Safety requirements for the American Board of Ophthalmology’s Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting MOC credit.

Your credit will be reported to the ABO within 30 days of claiming credit.

ABOHNS CC:  Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn their required annual part II self-assessment credit in the American Board Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning, Self-Assessment, Improvement in Medical Practice and/or Patient Safety requirements for the American Board of Ophthalmology’s Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting MOC credit.

Your credit will be reported to the ABO within 30 days of claiming credit.

ABPath MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 01.0 Lifelong Learning (Part II) / Self-Assessment Module (SAM) credits in the American Board of Pathology’s Maintenance of Certification Program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting MOC credit. 

Your credit will be reported to the ABPath within 60 days of claiming credit after the course. 

ABP MOC:  Successful completion of this CME activity, which includes participation in the activity and individual assessment of and feedback to the learner, enables the learner to earn up to 1.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit. 
Your credit will be reported to the ABP within 30 days of claiming credit. 

ABS MOC: This activity qualifies for 1.0 self-assessment credits toward Part 2 of the American Board of Surgery (ABS) Maintenance of Certification (MOC) Program.

Please Note:  It is the participant’s responsibility to self-report their participation to the American Board of Surgery, per board policy. 

Activity Director and Faculty

Activity Director

Anthony Fernandez, MD, PhD
Director, Medical and Inpatient Dermatology
W.D. Steck Chair of Clinical Dermatology
Medical Co-Director, Center for Continuing Education
Cleveland Clinic
Cleveland, OH

Faculty

Francisco J. Marco Canosa, MD, AAHIVS
Department of Infectious Diseases
Cleveland Clinic
Cleveland, OH

CME Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland Clinic Foundation be liable for any decision made or action taken in reliance upon the information provided through this CME activity.

Disclosures

In accordance with the Standards for Commercial Support issued by the Accreditation Council for Continuing Medical Education (ACCME), The Cleveland Clinic Foundation Center for Continuing Education requires resolution of all faculty conflicts of interest to ensure CME activities are free of commercial bias.

The following faculty have indicated that he may have a relationship, which in the context of his presentation(s), could be perceived as a potential conflict of interest:


Anthony Fernandez, MD, PhD  
Abbvie Pharmaceuticals Consulting
Membership on advisory committee or review panels
Teaching and Speaking
Celgene Corporation Consulting
Corbus Pharmaceuticals Research / Independent Contractor
Mallinckrodt Inc. Consulting
Research / Independent Contractor
Teaching and Speaking
Novartis Consulting
Research / Independent Contractor
Teaching and Speaking
Pfizer, Inc. Research / Independent Contractor
Roche Pharmaceuticals Principal Investigator for a Phase III Clinical Trial
UCB Consulting


The following faculty have indicated he has no relationship which, in the context of his presentation(s), could be perceived as a potential conflict of interest:

Francisco J. Marco Canosa, MD

 

This CME activity was produced by The Cleveland Clinic Foundation Center for Continuing Education.